In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

Pharmaceutical consultants apply their comprehensive expertise in different areas to accelerate the drug development process.

BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.

Biopharma companies require optimal clone yields to ensure maximum concentration and effectiveness of these therapeutic proteins. High titer capability is essential for delivering superior results and ...

Insilico is among the companies that deploy AI and robotics in hopes of speeding up the time-consuming drug development process and improving its success rate. Insilico said its technology could ...

Wu Kaimin was worried her dissertation proposal might not be approved. Now, her research could fundamentally alter how ...

Received Clearance from the U.S. Food and Drug Administration (FDA) for Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), ...

Joining us today are Oncocyte President and CEO, Josh Riggs; Chief Science Officer, Ekke Schutz; and CFO, Andrea James. We ...